The election results caused shares of U.S. pharmaceutical companies to rise, as the divided Congress is unlikely to reduce drug prices. Shares of Pfizer and AbbVie were up more than 3 percent on Nov. 7, while shares of Merck and Bristol-Myers Squibb were up more than 2 percent.
The election results and the legislative deadlock that is expected over the next two years also caused shares of major health insurers to jump.
Shares of Humana hit an all-time high Nov. 7 of $354.33, and shares of Anthem and UnitedHealth also hit records, according to Reuters.
More articles on healthcare finance:
The rural hospital closure crisis: 9 things to know
CMS overhauls home health payment model: 5 things to know
Tenet’s net loss shrinks amid $250M cost-cutting drive
